Female Malignancies and Immunotherapy: What's New?
- PMID: 33050485
- PMCID: PMC7600966
- DOI: 10.3390/cancers12102909
Female Malignancies and Immunotherapy: What's New?
Abstract
For many years, the therapeutic advances in gynecological neoplasms have remained steady, however, in recent years, the application of the most modern "-omics" sciences has shed light on the pathogenesis and on neoplastic progression, with important implications in the introduction of targeted treatments that are more effective and less toxic [...].
Conflict of interest statement
The authors declare no conflict of interest.
References
Publication types
LinkOut - more resources
Full Text Sources